Walleye Capital
AURA icon

Walleye Capital’s Aura Biosciences AURA Stock Holding History

Walleye Capital’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,371
Closed -$253K – 4379
2025
Q4 		$253K Sell
46,371
-20,925
-31% -$124K ﹤0.01% 3415
2025
Q3 		$416K Buy
+67,296
New +$440K ﹤0.01% 2765
2024
Q1 		– Sell
-18,015
Closed -$160K – 5409
2023
Q4 		$160K Buy
+18,015
New +$153K ﹤0.01% 3802

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Walleye Capital's AURA Position: Q1 2026 in Review

Walleye Capital sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 46,371 shares — an estimated $253K sold.

Walleye Capital first reported a position in AURA in Q4 2023 and held it in 3 quarters. The position peaked at $416K in Q3 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Walleye Capital reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 46,371 Aura Biosciences shares in Q1 2026, an estimated $253K.
  • Walleye Capital first reported a position in Aura Biosciences in Q4 2023 and held it in 3 quarters.
  • Walleye Capital's Aura Biosciences position peaked at $416K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.